The Fatty Liver Foundation has a question for liver disease patients. The FDA has delayed a decision on Intercept's NASH drug obeticholic acid (Ocaliva) We would like to know what you think of that.

Question Title

* 1. Were you aware the FDA was considering Ocaliva for approval for NASH?

Yes

No

Question Title

* 2. Are you aware that there are no drug treatments for NASH?

Yes

No

Question Title

* 3. To be approved as a NASH therapy the FDA required a one stage reduction in fibrosis. Do you feel that fibrosis reduction of one stage would be of value?

Yes

No

Question Title

* 4. If all a drug therapy did was to stop the progression of fibrosis would that be of value?

Yes

No

Question Title

* 5. Suppose a drug treatment only worked for less than half of the patients, would it still be useful to have it available?

Yes

No

Question Title

* 6. Would you support asking the FDA to reconsider?

Yes

No

Question Title

* 7. If you would like to make a personal comment please tell us what you think.